Corporate Governance
AddLife´s group management
From the left: Fredrik Dalborg, Peter Simonsbacka, Martin Almgren, Christina Rubenhag
FREDRIK DALBORG |
CHRISTINA RUBENHAG |
|
President and CEO Born: 1972 Member of Group Management since: 2022 |
CFO Born: 1970 Member of Group Management since: 2022 |
PETER SIMONSBACKA |
MARTIN ALMGREN |
|
Business Area Manager Labtech Född: 1960 Member of Group Management since: 2017 Education: Engineer Professional experience: Business area manager in Addtech Nordic AB, CEO BergmanLabora AB and Business area manager Mettler-Toledo AB Other appointments: Chairman of the Board for Swedish Labtech Holdings of shares in AddLife: 73,140 Class B shares as well as call options corresponding to 203,150 Class B shares |
Business Area Manager Medtech Född: 1976 Member of Group Management since: 2015 Education: M.Sc. Econ |
Information regarding shareholdings as of March 8, 2023.
The CEO, shall manage the operations in accordance with the Companies Act and within the framework established by the Board of Directors. The work and role of the CEO and the division of duties between the Board of Directors and the CEO are detailed in a written set of instructions set out by the Board of Directors (“Instructions to the CEO”). The Board of Directors continuously evaluates the work of the CEO. In consultation with the Chairman, the CEO has prepared the information needed to make decisions at Board meetings and has presented reports and reasoned proposals for decisions.
The CEO shall lead the work of the group management and make decisions in consultation with the other members of the group management. At the end of 2022, the group management consisted of six persons, Fredrik Dalborg, CEO, Christina Rubenhag, CFO, Martin Almgren, Business Area Manager for Medtech, Peter Simonsbacka, Business Area Manager for Labtech, Ulrika Hellman, Head of M&A, and Ove Sandin, Senior Advisor. After the end of the year, Ulrika Hellman left the company and Ove Sandin is no longer part of the management team. Former CEO Kristina Willgård left her role on August 31. Group management has regular business reviews under the management of the CEO.
Operational organisation
During the financial year, the Group’s operations were organised into two business areas – Labtech and Medtech. Operations are conducted in subsidiaries mainly in Europe but also in Australia and China. Each operating Company has a board of directors in which the Company’s CEO and senior executives from the business area are represented. Each company president reports to a business division manager or business area manager, who, in turn reports to the CEO for AddLife AB.